A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis

AG Granja, F Carrillo-Salinas, A Pagani… - Journal of Neuroimmune …, 2012 - Springer
Phytocannabinoids like∆ 9-tetrahydrocannabinol (THC) and cannabidiol (CBD) show a
beneficial effect on neuroinflammatory and neurodegenerative processes through cell …

[HTML][HTML] Cannabinoids as multifaceted compounds

D Persia, F Mangiavacchi, MC Marcotullio, O Rosati - Phytochemistry, 2023 - Elsevier
Since ancient times, Cannabis and its preparations have found various applications such as
for medical, recreational and industrial purposes. Subsequently the 1930s, legislation in …

Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease

S Badal, KN Smith, R Rajnarayanan - Pharmacology & therapeutics, 2017 - Elsevier
The organized, tightly regulated signaling relays engaged by the cannabinoid receptors
(CBs) and their ligands, G proteins and other effectors, together constitute the …

Chromenopyrazole-based high affinity, selective fluorescent ligands for cannabinoid type 2 receptor

S Singh, CRM Oyagawa, C Macdonald… - ACS Medicinal …, 2019 - ACS Publications
Cannabinoid type 2 receptor (CB2R) is an attractive target for the treatment of pain and
inflammatory disorders. Availability of a selective CB2R fluorescent ligand to study CB2R …

Chromenopyrazole, a versatile cannabinoid scaffold with in vivo activity in a model of multiple sclerosis

P Morales, M Gómez-Cañas, G Navarro… - Journal of medicinal …, 2016 - ACS Publications
A combination of molecular modeling and structure–activity relationship studies has been
used to fine-tune CB2 selectivity in the chromenopyrazole ring, a versatile CB1/CB2 …

Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease

P González-Naranjo, N Pérez-Macias… - European journal of …, 2014 - Elsevier
Designing drugs with a specific multi-target profile is a promising approach against
multifactorial illnesses as Alzheimer's disease. In this work, new indazole ethers that …

Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor**

P Morales, G Navarro, M Gómez‐Autet… - … A European Journal, 2020 - Wiley Online Library
Single chemical entities with potential to simultaneously interact with two binding sites are
emerging strategies in medicinal chemistry. We have designed, synthesized and functionally …

Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity

P Morales, D Vara, M Gomez-Canas, MC Zúñiga… - European Journal of …, 2013 - Elsevier
Chromenopyrazolediones have been designed and synthesized as anticancer agents using
the multi-biological target concept that involves quinone cytotoxicity and cannabinoid …

Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against Triple-Negative Breast Cancer

P Morales, S Blasco-Benito, C Andradas… - Journal of medicinal …, 2015 - ACS Publications
Triple-negative breast cancer (TNBC) represents a subtype of breast cancer characterized
by high aggressiveness. There is no current targeted therapy for these patients whose …

Cannabis and bioactive cannabinoids

F Messina, O Rosati, M Curini… - Studies in natural products …, 2015 - Elsevier
The therapeutic use of Cannabis dates back to ancient times and this plant has been used
for centuries as remedy for a large number of diseases. Today it is well known that biological …